PillOTC · Liquid · Oral
Influenzinum (2022-2023)
Influenza A Virus A/Darwin/9/2021 Ivr-228 (H3n2) Antigen (Uv, Formaldehyde Inactivated) + Influenza A Virus A/Victoria/2570/2019 Ivr-215 (H1n1) Antigen (Uv, Formaldehyde Inactivated) + Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Uv, Formaldehyde Inactivated) + Influenza B Virus B/Phuket/3073/2013 Antigen (Uv, Formaldehyde Inactivated)
0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US1 NDCs
0 active makers
0 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers1 labelers
Packages1
DEA / ScheduleNone
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Energique, Inc. | unknown | 1 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.